Cargando…

The safety of multiple oral immunotherapy in phase one studies at a single center

Detalles Bibliográficos
Autores principales:	Dominguez, TLR, Mehrotra, A, Wilson, S, Winterroth, L, Blakemore, A, Sampson, K, Nadeau, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723479/ http://dx.doi.org/10.1186/2045-7022-3-S3-O25

Ejemplares similares

Safety and feasibility of oral immunotherapy to multiple allergens for food allergy
por: Bégin, Philippe, et al.
Publicado: (2014)

Erratum to: Safety and feasibility of oral immunotherapy to multiple allergens for food allergy
por: Bégin, Philippe, et al.
Publicado: (2016)

Safety and predictors of adverse events during oral immunotherapy with raw egg white
por: Vazquez-Ortiz, M, et al.
Publicado: (2013)

Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab
por: Bégin, Philippe, et al.
Publicado: (2014)

CCR9+ and CD103+ tolerogenic dendritic cell populations in food allergy patients undergoing oral immunotherapy
por: Garcia, Marco, et al.
Publicado: (2011)

T cell specific and non specific tolerance mechanisms in peanut oil immunotherapy in peanut allergic subjects
por: Singh, Amit, et al.
Publicado: (2011)

Oral immunotherapy be heated ovomuciod-reduced egg white in a Balb/C mouse model
por: Jiménez-Saiz, Rodrigo, et al.
Publicado: (2011)

S116: LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON—TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
por: Kuo, K, et al.
Publicado: (2022)

5589320 FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE CELL DISEASE
por: van Dijk, M.J., et al.
Publicado: (2023)

Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric subjects
por: Otani, Iris M, et al.
Publicado: (2014)

Immunotherapy of cancer
por: McKenzie, I
Publicado: (2003)

Evaluation of peach tolerance after one year of sublingual immunotherapy with LTP (Pru p 3) in allergic patients sensitises to food by LTPs
por: Bagos, Gador, et al.
Publicado: (2015)

O12 - Specific IgE levels for goat’s and sheep’s milk after successful oral immunotherapy to cow’s milk in children
por: Villafana, Liseth, et al.
Publicado: (2014)

Focused ultrasound and immunotherapy
por: Hurwitz, Mark
Publicado: (2015)

Allergic reactions due to cow’s milk (CM) doses and triggering factors in 40 CM anaphylactic children during maintenance phase of specific oral tolerance induction (SOTI) treatment to CM in our unit
por: Vazquez, Marta, et al.
Publicado: (2011)

Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
por: Goepfert, P, et al.
Publicado: (2012)

S103: TRIAL IN PROGRESS: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF THE PKR ACTIVATOR ETAVOPIVAT (FT-4202) IN PATIENTS WITH THALASSEMIA OR SICKLE CELL DISEASE
por: Lal, A., et al.
Publicado: (2022)

TG4010 immunotherapy combined with first-line therapy in advanced non-small cell lung cancer (NSCLC): phase IIb results of the TIME study
por: Quoix, Elisabeth, et al.
Publicado: (2014)

In-vivo validation of interpolation-based phase offset correction in MR flow quantification: a multi-vendor, multi-center study
por: Hofman, Mark B, et al.
Publicado: (2016)

Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-naïve, HIV-1-infected patients
por: Cohen, C, et al.
Publicado: (2010)

OA05-06 LB. First-in-human Phase 1 safety and immunigenicity of an adenovirus serotype 26 HIV-1 vaccine vector
por: Baden, LR, et al.
Publicado: (2009)

Familial Mediterranean Fever in childhood: a single center experience
por: Barut, K, et al.
Publicado: (2015)

In vitro immunomonitoring of insect venom-allergic patients on immunotherapy
por: Cifuentes, Liliana, et al.
Publicado: (2014)

HIFU immunotherapy: lessons from animal to clinical studies
por: Wu, Feng
Publicado: (2015)

Immunotherapy: SAFETY AND EFFICACY OF SARS-COV-2-SPECIFIC T CELLS AS ADOPTIVE IMMUNOTHERAPY FOR HIGH-RISK COVID-19 PATIENTS: A PHASE I/II, RANDOMIZED CLINICAL TRIAL
por: Papadopoulou, A., et al.
Publicado: (2022)

Effectiveness of canakinumab treatment in Schnitzler's syndrome: a multi-center randomized placebo-controlled study
por: Krause, K, et al.
Publicado: (2015)

Comparing active treatments at phase II: using multiple criteria to find the optimal treatment to take forward to phase III
por: Sweeting, Michael, et al.
Publicado: (2013)

A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel spiroindolone KAE609, to assess the safety, tolerability and pharmacokinetics in healthy adult volunteers
por: Leong, Joel, et al.
Publicado: (2014)

Can immunotherapy be useful for a « functional cure » of HIV infection?
por: Vanham, Guido
Publicado: (2011)

Efficacy and safety of canakinumab, a long acting fully human anti-Interleukin-1β antibody, in systemic juvenile idiopathic arthritis with active systemic features: results from a phase III study
por: Ruperto, N, et al.
Publicado: (2011)

A14 TRANSABDOMINAL BOWEL ULTRASOUND AND CLINICAL OUTCOMES OVER ONE YEAR IN CHILDREN WITH NEWLY DIAGNOSED CROHN’S DISEASE
por: Hudson, A, et al.
Publicado: (2023)

A cohesive multidisciplinary team approach to the management of patients with eating disorders
por: Braham, Sarah, et al.
Publicado: (2013)

P056 Oral Ibrexafungerp outcomes by fungal disease in patients from an interim analysis of a Phase 3 Open-label Study (FURI)
por: Prattes, Juergen, et al.
Publicado: (2022)

Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes
por: Wilkie, S, et al.
Publicado: (2008)

Focused ultrasound: an effective technique for unleashing the power of immunotherapy in the tumor microenvironment?
por: Repasky, Elizabeth
Publicado: (2015)

Direct nanodroplet and microbubble comparison for high intensity focused ultrasound ablation enhancement and safety
por: Moyer, Linsey, et al.
Publicado: (2015)

Single center experience with carotico-subclavian bypass
por: Kucuker, A, et al.
Publicado: (2013)

S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL
por: Achebe, M, et al.
Publicado: (2022)

Effect of flow angle and flow profile on phase contrast flow measurements: overestimation at extreme angles and skewed profiles
por: Whitehead, Kevin K, et al.
Publicado: (2009)

Oral presentations
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_2h8orq0db8aorb3dhdhssoquan